Inhibition of the Notch pathway with GSI LSN-411575 has been proven to block NSCLC tumor growth in vivo in Kras murine models, where, in addition to inducing Hes1 downregulation, it affects ERK phosphorylation, inhibits cell proliferation and increases apoptosis [87]. Here, KRAS is linked to non-small cell lung carcinoma.